Inhibition of Ebola Virus by a Molecularly Engineered Banana Lectin

Ebolaviruses cause an often rapidly fatal syndrome known as Ebola virus disease (EVD), with average case fatality rates of ~50%. There is no licensed vaccine or treatment for EVD, underscoring the urgent need to develop new anti-ebolavirus agents, especially in the face of an ongoing outbreak in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Covés-Datson, Evelyn M., Dyall, Julie, DeWald, Lisa Evans, King, Steven R., Dube, Derek, Legendre, Maureen, Nelson, Elizabeth, Drews, Kelly C., Gross, Robin, Gerhardt, Dawn M., Torzewski, Lisa, Postnikova, Elena, Liang, Janie Y., Ban, Bhupal, Shetty, Jagathpala, Hensley, Lisa E., Jahrling, Peter B., Olinger, Gene G., White, Judith M., Markovitz, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6687191/
https://www.ncbi.nlm.nih.gov/pubmed/31356611
http://dx.doi.org/10.1371/journal.pntd.0007595

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6687191/
https://www.ncbi.nlm.nih.gov/pubmed/31356611
http://dx.doi.org/10.1371/journal.pntd.0007595

Ejemplares similares